FAM
RXDX

Fred Alger Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Fred Alger Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$143M Sell
2022
Q4 		$150M Buy
2022
Q3 		$61.1M Buy
2022
Q2 		$6.88M Buy
2022
Q1 		$5.01M Sell
2021
Q4 		$6.82M Buy